Stallen South Asia Hosts Technical Seminar and Launches New Vaccines in Coimbatore

Coimbatore, Tamil Nadu — 12th September 2025 — Stallen South Asia Pvt. Ltd., a trusted partner to India’s poultry sector for over 26 years, recently organized an exclusive technical seminar for leading poultry farmers from Tamil Nadu and Kerala. The event underscored Stallen’s enduring commitment to the region while introducing two innovative vaccines — BIO-VAC SGP 695 and LIVACOX Q — which received an enthusiastic response from participants.

Held in Coimbatore, the program brought together 30+ progressive poultry farmers who play a vital role in strengthening South India’s poultry industry and economy. The gathering created a platform to exchange knowledge, discuss emerging challenges, and explore practical solutions for healthier, more productive flocks.

The session opened with a warm welcome by Mr. Raja Desingu, Regional Sales Manager, who thanked attendees for their continued trust in Stallen.

Dr. Sanjay Singhal, Chief Operating Officer of Stallen South Asia, followed with an insightful presentation on the company’s journey and growth in the Indian poultry market. He highlighted Stallen’s “farmer-first” philosophy, combining field expertise with cutting-edge science to deliver sustainable, performance-oriented solutions.

A key highlight of the seminar was an expert talk by Dr. Jayaraman, a renowned poultry consultant from South India. Addressing the theme “Safeguarding Poultry Health: Prevention of Hidden Threats in Breeders & Layers,” he shared strategies to protect flocks from often-overlooked diseases such as Mycoplasma (MG and MS), Coccidiosis, and Salmonella. He emphasized the importance of early detection, robust immunity, and sound farm management in mitigating these risks.

Adding to the technical insights, Dr. Kishor Gedam presented a comprehensive overview of Stallen’s vaccine portfolio. He detailed the benefits of killed vaccines such as MS-VACMYC-VAC, and CORI-VAC, as well as live vaccines including BIO-VAC SGP 695 and LIVACOX Q, which help safeguard birds against Mycoplasma, Salmonella, and Coccidiosis.

The event concluded with an informal networking dinner, offering farmers and Stallen’s technical team an opportunity to strengthen relationships and share perspectives in a relaxed setting.

By bringing together expertise, innovation, and field experience, this seminar reaffirmed Stallen South Asia’s dedication to empowering poultry farmers in Tamil Nadu and Kerala with trusted products, strong technical support, and long-term partnerships for sustainable growth.

NSPDT Delegation Visits Stallen South Asia’s Feed Additives and Therapeutics Units in Palghar, Maharashtra.

The National Smallholder Poultry Development Trust (NSPDT) delegation recently visited the advanced manufacturing facilities of Stallen South Asia Pvt. Ltd. in Palghar, Maharashtra. The visit included a tour of the Feed Additives Manufacturing Plant in Chahade and the Therapeutics/Formulations Manufacturing Unit in Vevoor. The purpose of the visit was to understand modern practices in animal health and nutrition. The delegation included Dr. Mokadesh Ali, Dr. Babul Borgohain, Dr. Dula Talukdar, Mr. Abhilash Kumar Jha, Mr. Akhilesh Kumar Verma, Mr. Anirban Mukerjee, Mr. Anupam Kumar, Mr. Gopal Kumar Prasad, and Mr. Suraj Kumar Pandey. They were warmly welcomed by Stallen’s leadership team and were given detailed insights into the company’s manufacturing processes, quality control systems, and innovation efforts.

“Stallen’s Feed additives and supplement manufacturing facilities in Chahade” is recognized for its world-class infrastructure and manufacturing excellence. It specializes in a broad portfolio of feed additives and supplements for poultry and cattle, including antibacterial solutions, treatments targeting mycoplasmal infections, deworming agents, performance enhancers, anthelmintics, mineral supplements, toxin-binding formulations, antidiarrheals, growth promoters, anticoccidials, water sanitation products, fly control solutions, and disinfectants.

These products are meticulously crafted and made available in various convenient forms such as tablets, boluses, powders, oral liquid solutions. The manufacturing unit is equipped with advanced machinery for formulation, granulation, liquid filling, and packaging. Rigorous quality control is implemented at every stage, from raw material testing to final product release, ensuring product consistency, safety, and compliance with global standards.

Another dedicated “Therapeutics/Formulations Manufacturing Unit in Vevoor (Palghar, Maharashtra)” is a crucial facility for manufacturing pharmaceutical products that range between regular therapeutic drugs as well as beta-lactam formulations. This formulation unit is equipped with state-of-the-art facilities and machinery required for the formulation and production of pharmaceutical products. This includes equipment for mixing, blending, granulation, drying, and packaging. The capacities are built for effervescent tablets, liquid form (oral and topical), oral powder, bolus and ointment. The facilities comply with Good Manufacturing Practices (GMP) and are aligned with regulatory requirements to serve both domestic and international markets. With their company products registered in over 65 countries, this milestone reinforces India’s pursuit of veterinary self-sufficiency and innovation-led growth.

During the visit, the delegation had meaningful interactions with key team members including Mr. Aniket Parikh (Director), Dr. Sanjay Singhal (COO – Poultry & Cattle), Dr. Amit Janbandhu (Product Manager – Nutrition), Dr. Onkar Paradhe (Vaccine Division), Mr. Vijaykumar Menon (Factory Manager – Chahade), and Mr. Sunil Sonwane (Factory Manager – Palghar).

Mr. Aniket Parikh shared that Stallen was founded in 1992 by his late father, Shri A.B. Parikh, and now exports products to over 65 countries including those in North and South America, Europe, the Middle East, China, Japan, Southeast Asia, and Australia. Dr. Sanjay Singhal also highlighted their third manufacturing unit in Vatva, Gujarat, which produces Halquinol 98%, a non-antibiotic growth promoter made according to British Pharmacopoeia 1980 (BP 80) standards. Dr. Amit Janbandhu mentioned Stallen’s collaboration with FATRO, Italy, through which they market FATRO’s complete vaccine range in the Indian subcontinent, and highlighted Stallen’s product portfolio.

The delegation appreciated the company’s warm hospitality, transparency, and strong commitment to quality. The visit highlighted the vital role Stallen plays in advancing India’s veterinary sector through innovation, regulatory compliance, and responsible manufacturing.

WhatsApp Bot